Welcome to LookChem.com Sign In|Join Free

CAS

  • or

187827-14-1

Post Buying Request

187827-14-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

187827-14-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 187827-14-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,7,8,2 and 7 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 187827-14:
(8*1)+(7*8)+(6*7)+(5*8)+(4*2)+(3*7)+(2*1)+(1*4)=181
181 % 10 = 1
So 187827-14-1 is a valid CAS Registry Number.

187827-14-1Relevant articles and documents

The decarboxylative blaise reaction

Jae, Hoon Lee,Bo, Seung Choi,Jay, Hyok Chang,Hee, Bong Lee,Yoon, Joo-Yong,Lee, Jaeick,Shin, Hyunik

, p. 10261 - 10263 (2007)

(Chemical Equation Presented) Reaction of aryl nitriles with potassium ethyl malonate in the presence of zinc chloride and a catalytic amount of Huenig's base provided β-amino acrylates in moderate to good yield. Compared to the classical Blaise reaction,

Regioselective Synthesis of N2-Aryl 1,2,3-Triazoles via Electro-oxidative Coupling of Enamines and Aryldiazonium Salts

Baidya, Mrinmay,Mallick, Samrat,De Sarkar, Suman

, p. 1274 - 1279 (2022/02/14)

An efficient synthetic route for the construction of N2-aryl 1,2,3-triazoles is reported via sequential C-N bond formation and electro-oxidative N-N coupling under metal-free conditions. Readily accessible 2-aminoacrylates and aryldiazonium salts were used as starting materials, and the developed protocol displays excellent functional group tolerance, allowing an extensive range of substrate scope up to 91% isolated yield. Various mechanistic studies, along with the isolation of an intermediate adduct, refer to successive ionic and radical reaction sequences.

Phenyl derivatives, their manufacture and use as pharmaceutical agents

-

Page/Page column 45-46, (2010/02/11)

This invention relates to compounds of the formula wherein one of R5, R6 and R7 is and X1, X2, Y1 to Y4, R1 to R13 and m and n are defined in the description, and to all enantiomers and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARδ and/or PPARα agonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 187827-14-1